ZYME – zymeworks inc. (US:NASDAQ)
Stock Stats
News
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
Zymeworks Inc. (NYSE: ZYME) had its price target raised by analysts at HC Wainwright from $12.00 to $13.00. They now have a "neutral" rating on the stock.
Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates [Yahoo! Finance]
Zymeworks Inc. (NYSE: ZYME) had its price target raised by analysts at Citigroup Inc. from $18.00 to $19.00. They now have a "buy" rating on the stock.
Form 4 Zymeworks Inc. For: Mar 31 Filed by: NODELMAN OLEG
Form 4 Zymeworks Inc. For: Mar 25 Filed by: NODELMAN OLEG
Form 4 Zymeworks Inc. For: Mar 20 Filed by: NODELMAN OLEG
Form 4 Zymeworks Inc. For: Mar 17 Filed by: NODELMAN OLEG
Form SCHEDULE 13D/A Zymeworks Inc. Filed by: EcoR1 Capital, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.